US Stock MarketDetailed Quotes

MYCOF Mydecine Innovations

Watchlist
  • 0.014400
  • +0.014300+14300.00%
Close Mar 27 16:00 ET
756.97KMarket Cap-16P/E (TTM)

About Mydecine Innovations Company

Mydecine Innovations Group, Inc. is a biotechnology company. It engages in the business of creating the latest novel drugs and therapies to treat mental health conditions like nicotine addiction and post-traumatic stress disorder. The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.

Company Profile

SymbolMYCOF
Company NameMydecine Innovations
Founded2013
MarketPink Market
Employees3
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address789 West Pender Street,Suite 810
CityVancouver
ProvinceBritish Columbia
CountryCanada
Zip CodeV6C 1H2
Phone1-604-687-2038

Company Executives

  • Name
  • Position
  • Salary
  • David Joshua Bartch
  • Director and Chief Executive Officer
  • --
  • Damon Michaels
  • Director and Chief Operating Officer
  • --
  • Dean Ditto
  • Chief Financial Officer
  • --
  • Dr. Rakesh Jetly
  • Chief Medical Officer
  • --
  • Robert Roscow
  • Director and Chief Scientific Officer
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg